Immunity to and frequency of reinfection with respiratory syncytial virus.
about
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G proteinRespiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cellsIn Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusSystems biology from virus to humansAnimal models of respiratory syncytial virus infection and diseaseDendritic cells in human Pneumovirus and Metapneumovirus infectionsBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityCX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerA novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent modelsPhylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in childrenAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentRSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In VivoRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter monthsAntiviral natural products and herbal medicines.Intranasal antibody prophylaxis for protection against viral disease.A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard.Respiratory syncytial virus impairs macrophage IFN-alpha/beta- and IFN-gamma-stimulated transcription by distinct mechanisms.Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeRespiratory syncytial virus genetic and antigenic diversity.Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.Humoral immunity to human metapneumovirus infection in adultsSubversion of pulmonary dendritic cell function by paramyxovirus infectionsRespiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responseTreatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in miceMapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).Immune responses and disease enhancement during respiratory syncytial virus infectionLow CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus.Respiratory syncytial virus infection in adultsRespiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.Respiratory syncytial virus vaccinesEvaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea.Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended.Molecular epidemiology of respiratory syncytial virus.Respiratory syncytial virus infections in the adult asthmatic--mechanisms of host susceptibility and viral subversion.Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
P2860
Q24531958-C1B67999-29A9-4AE4-BC4B-99131D971128Q24681094-564402B3-EB1C-45AE-961D-8A61A3B24418Q26748856-FAA44B92-8346-4AC8-B87E-9A64027424C6Q26798272-EF634A0C-F31C-4441-BCF1-C662C0A911EEQ26801458-4E77BEB6-BA58-458E-BE0E-3A2C229A3F8EQ26865337-8AF81C40-103B-4F99-9F9F-581B38313D28Q27010165-AFF43019-C2E5-4A1A-A7D1-320D3CEA40CEQ27303940-EBE25F81-1D4D-4D60-BD17-57D42BC0F760Q27312129-5C5C7C92-C2D1-4681-87C0-AB94C9173BAFQ27329785-686072B5-55E4-4117-ADA8-B19288DABF01Q28080556-406C176F-845C-438E-BC6A-11CA89CB485CQ28548423-1ADE9EF2-94D1-4E80-A436-AD2F434468EFQ30240274-2FBA1613-7716-4FD8-9E46-CAC1B525036DQ30485791-730F2575-5316-410A-810F-99364D57DF4CQ33234270-8E6F0738-E65F-4190-B124-29EACD6A4F32Q33558356-24112A6D-BA37-48EA-A3D5-BC2527A8170DQ33593841-28B1CFA9-18B9-4272-8515-0F6A8DF90DC8Q33596559-5BCBA0DA-3EA7-4219-948B-3EE5E9F62E08Q33657624-259234CF-3453-4541-9795-ADB924C072D6Q33683058-3D1FB271-7AA6-4BA6-9B77-561BC1F7C58FQ33712575-C312B1F4-042F-4357-84F8-7849DD2F8838Q33766415-F4AF165B-94BE-46BE-9BBD-4EA5ED854300Q33783066-2D2FD923-EF9F-4CC1-A7E0-6A518A325592Q33812405-D54FB606-5464-4205-9E2B-72E80F1C1E07Q33813095-C9BF9919-BCF6-4945-A3C4-5A657D3467B2Q33830543-664A3C50-FDBA-4BA9-9B75-352460E44974Q33832308-54EA0DF7-653A-46F0-832C-6C8F52B6E032Q33886159-A49E9FAA-5EF3-4001-BCF4-771BC2521DBCQ33920501-7EF94E4D-ED65-42C8-B1B1-02CD83C9BBDCQ33932941-D73A46DC-1D7F-4718-B8E0-FD2A0046B814Q33937152-B900683D-4B1A-44A0-A450-93845F171051Q33951970-1F4431AF-5E7E-4478-92F0-D8C00D98C30AQ33961877-56079809-07EF-4537-992C-631052F25392Q33964142-3973B0D2-103E-4D54-A02F-2664E7532402Q33975330-E3281A3C-6FD8-4554-9A5C-3D2CCEEE0D7BQ34018856-BFDE2B9B-F59E-48F9-BBDB-2537E67C04E4Q34033632-A828BC73-8D19-4B66-9CDA-BF55DDA792B8Q34191801-BC5823AD-5659-41E6-9296-E7FDD3D284C1Q34254742-56A0A44C-4176-493B-A79D-C327BAB794F8Q34262180-FCA10CF3-8989-450E-9DA4-27AF0B236D2B
P2860
Immunity to and frequency of reinfection with respiratory syncytial virus.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Immunity to and frequency of reinfection with respiratory syncytial virus.
@en
Immunity to and frequency of reinfection with respiratory syncytial virus.
@nl
type
label
Immunity to and frequency of reinfection with respiratory syncytial virus.
@en
Immunity to and frequency of reinfection with respiratory syncytial virus.
@nl
prefLabel
Immunity to and frequency of reinfection with respiratory syncytial virus.
@en
Immunity to and frequency of reinfection with respiratory syncytial virus.
@nl
P2093
P356
P1476
Immunity to and frequency of reinfection with respiratory syncytial virus.
@en
P2093
P304
P356
10.1093/INFDIS/163.4.693
P407
P577
1991-04-01T00:00:00Z